3,400 Shares in Balchem Co. (NASDAQ:BCPC) Acquired by PDT Partners LLC

PDT Partners LLC acquired a new stake in shares of Balchem Co. (NASDAQ:BCPC) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 3,400 shares of the basic materials company’s stock, valued at approximately $598,000.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Janus Henderson Group PLC lifted its position in Balchem by 21.3% during the first quarter. Janus Henderson Group PLC now owns 18,059 shares of the basic materials company’s stock valued at $2,795,000 after purchasing an additional 3,176 shares during the period. Tidal Investments LLC acquired a new position in shares of Balchem in the 1st quarter valued at about $265,000. Cetera Advisors LLC acquired a new stake in Balchem during the first quarter worth about $321,000. OLD National Bancorp IN acquired a new stake in Balchem during the second quarter worth about $234,000. Finally, Annex Advisory Services LLC lifted its holdings in Balchem by 8.9% in the second quarter. Annex Advisory Services LLC now owns 4,319 shares of the basic materials company’s stock valued at $665,000 after acquiring an additional 352 shares during the period. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. HC Wainwright raised their price objective on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th.

Balchem Trading Up 0.3 %

Shares of NASDAQ:BCPC opened at $181.08 on Tuesday. The business’s 50 day moving average price is $174.56 and its 200-day moving average price is $167.78. Balchem Co. has a 1 year low of $124.34 and a 1 year high of $186.03. The firm has a market capitalization of $5.89 billion, a price-to-earnings ratio of 48.68, a price-to-earnings-growth ratio of 5.39 and a beta of 0.65. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.